Lifecore Biomedical
LFCR
LFCR
96 hedge funds and large institutions have $288M invested in Lifecore Biomedical in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 32 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.55% less ownership
Funds ownership: 93.34% → 90.79% (-2.6%)
62% less call options, than puts
Call options by funds: $10K | Put options by funds: $26K
Holders
96
Holding in Top 10
2
Calls
$10K
Puts
$26K
Top Buyers
1 | +$6.67M | |
2 | +$4.98M | |
3 | +$3.61M | |
4 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$2.3M |
5 |
BlackRock
New York
|
+$1.64M |
Top Sellers
1 | -$15.1M | |
2 | -$4.41M | |
3 | -$1.2M | |
4 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$1.12M |
5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$845K |